External Validation of the 2019 Briganti Nomogram for the Identification of Prostate Cancer Patients Who Should Be Considered for an Extended Pelvic Lymph Node DissectionGiorgio Gandaglia, Alberto Briganti, Romain Mathiéu et al.|European Urology|2020Cited by 92
Is There an Impact of Transperineal Versus Transrectal Magnetic Resonance Imaging–targeted Biopsy on the Risk of Upgrading in Final Pathology in Prostate Cancer Patients Undergoing Radical Prostatectomy? An European Association of Urology-Young Academic Urologists Prostate Cancer Working Group Multi-institutional StudyFabio Zattoni, Giorgio Gandaglia, Giancarlo Marra et al.|European Urology Focus|2023Cited by 24
Unilateral Pelvic Lymph Node Dissection in Prostate Cancer Patients Diagnosed in the Era of Magnetic Resonance Imaging–targeted Biopsy: A Study That Challenges the DogmaAlberto Martini, Massimo Valério, Lieke Wever et al.|The Journal of Urology|2023Cited by 22
Assessment of Health-Related Quality of Life in Patients with Advanced Prostate Cancer—Current State and Future PerspectivesAlexander Kretschmer, Roderick C.N. van den Bergh, Alberto Martini et al.|Cancers|2021Cited by 15
An updated model for predicting side-specific extraprostatic extension in the era of MRI-targeted biopsyAlberto Martini, Massimo Valério, Lieke Wever et al.|Prostate Cancer and Prostatic Diseases|2024Cited by 8